Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Aia Assaf-Casals & Ghassan Dbaibo. (2016) Meningococcal quadrivalent tetanus toxoid conjugate vaccine (MenACWY-TT, Nimenrix™): A review of its immunogenicity, safety, co-administration, and antibody persistence. Human Vaccines & Immunotherapeutics 12:7, pages 1825-1837.
Read now
Read now
Yorgo C Zahlanie, Moza M Hammadi, Soha T Ghanem & Ghassan S Dbaibo. (2014) Review of meningococcal vaccines with updates on immunization in adults. Human Vaccines & Immunotherapeutics 10:4, pages 995-1007.
Read now
Read now
Carine P Hedari, Rima W Khinkarly & Ghassan S Dbaibo. (2014) Meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine: a new conjugate vaccine against invasive meningococcal disease. Infection and Drug Resistance 7, pages 85-99.
Read now
Read now
Soha Ghanem, Sara Hassan, Randa Saad & Ghassan S Dbaibo. (2013) Quadrivalent meningococcal serogroups A, C, W, and Y tetanus toxoid conjugate vaccine (MenACWY-TT): a review. Expert Opinion on Biological Therapy 13:8, pages 1197-1205.
Read now
Read now
Articles from other publishers (18)
Yi Mo, Yanan Li, Gang Liu, Junji Chen, Dingkai Wei, Jigang Wu, Qiuyan Meng, Zhi Li & Zhaojun Mo. (2022) A phase II, single-center, randomized, double-blind, parallel control clinical study evaluating the immunogenicity and safety of a two-dose schedule of serogroups ACYW meningococcal polysaccharide conjugate vaccine. Vaccine 40:47, pages 6785-6794.
Crossref
Crossref
Sandra Guedes, Isabelle Bertrand-Gerentes, Keith Evans, Florence Coste & Philipp Oster. (2022) Invasive meningococcal disease in older adults in North America and Europe: is this the time for action? A review of the literature. BMC Public Health 22:1.
Crossref
Crossref
Thomas Bentley, Elizabeth Jones, Celina Jin, Maria Moore, Jonathon Gardner, Jennifer Hill & Andrew J. Pollard. (2021) Persistence of Antibody After a Vi-Tetanus Toxoid Conjugate Vaccine and Effect of Boosting With a Plain Polysaccharide Vaccine on Vi Antibody and Antigen-Specific B Cells. Frontiers in Tropical Diseases 2.
Crossref
Crossref
Salihu Sabiu Musa, Shi Zhao, Nafiu Hussaini, Abdulrazaq Garba Habib & Daihai He. (2020) Mathematical modeling and analysis of meningococcal meningitis transmission dynamics. International Journal of Biomathematics 13:01, pages 2050006.
Crossref
Crossref
Wisam Salim Hassan, Paula R. Giaretta, Raquel Rech, Morgane Ollivault-Shiflett & Maria D. Esteve-Gasent. (2019) Enhanced protective efficacy of Borrelia burgdorferi BB0172 derived-peptide based vaccine to control Lyme disease. Vaccine 37:37, pages 5596-5606.
Crossref
Crossref
Luis Rivera, Tino F. Schwarz, Kyung-Hyo Kim, Yun-Kyung Kim, Ulrich Behre, Sung-Ho Cha, Dae Sun Jo, Jacob Lee, Jin-Soo Lee, Brigitte Cheuvart, Archana Jastorff & Marie Van der Wielen. (2018) Immunogenicity and safety of the quadrivalent meningococcal vaccine MenACWY-TT co-administered with a combined diphtheria-tetanus-acellular pertussis vaccine versus their separate administration in adolescents and young adults: A phase III, randomized study. Vaccine 36:31, pages 4750-4758.
Crossref
Crossref
Nicola P. Klein, Tomas Habanec, Pavel Kosina, Nirmish R. Shah, Devayani Kolhe, Jacqueline M. Miller, Marjan Hezareh & Marie Van der Wielen. (2018) Immunogenicity and safety of the quadrivalent meningococcal ACWY-tetanus toxoid conjugate vaccine (MenACWY-TT) in splenectomized or hyposplenic children and adolescents: Results of a phase III, open, non-randomized study. Vaccine 36:17, pages 2356-2363.
Crossref
Crossref
Pumtiwitt C. McCarthy, Abeer Sharyan & Laleh Sheikhi Moghaddam. (2018) Meningococcal Vaccines: Current Status and Emerging Strategies. Vaccines 6:1, pages 12.
Crossref
Crossref
Nicola J. Beresford, Angela Martino, Ian M. Feavers, Michael J. Corbel, Xilian Bai, Ray Borrow & Barbara Bolgiano. (2017) Quality, immunogenicity and stability of meningococcal serogroup ACWY-CRM 197 , DT and TT glycoconjugate vaccines. Vaccine 35:28, pages 3598-3606.
Crossref
Crossref
Joseph Torresi, Abinash Virk & Jane N. Zuckerman. 2015. Essential Travel Medicine. Essential Travel Medicine
131
163
.
Weilin Qiao, Shaoyang Ji, Yubao Zhao & Tao Hu. (2015) Conjugation of β-glucan markedly increase the immunogencity of meningococcal group Y polysaccharide conjugate vaccine. Vaccine 33:17, pages 2066-2072.
Crossref
Crossref
Paolo Pellegrino, Valentina Perrone, Sonia Radice, Annalisa Capuano & Emilio Clementi. (2015) Immunogenicity of meningococcal quadrivalent (serogroup A, C, W135 and Y) tetanus toxoid conjugate vaccine: Systematic review and meta-analysis. Pharmacological Research 92, pages 31-39.
Crossref
Crossref
S. Pecetta, P. Lo Surdo, M. Tontini, D. Proietti, C. Zambonelli, M.J. Bottomley, M. Biagini, F. Berti, P. Costantino & M.R. Romano. (2015) Carrier priming with CRM197 or diphtheria toxoid has a different impact on the immunogenicity of the respective glycoconjugates: Biophysical and immunochemical interpretation. Vaccine 33:2, pages 314-320.
Crossref
Crossref
Hiroki Ando, Robert Citorik, Sara Cleto, Sebastien Lemire, Mark Mimee & Timothy Lu. 2014. Novel Antimicrobial Agents and Strategies. Novel Antimicrobial Agents and Strategies
109
180
.
Francesca Micoli, Maria Rosaria RomanoMarta TontiniEmilia Cappelletti, Massimiliano Gavini, Daniela ProiettiSimona Rondini, Erwin SwennenLaura SantiniSara FilippiniCristiana BalocchiRoberto AdamoGerd PluschkeGunnstein Norheim, Andrew PollardAllan Saul, Rino RappuoliCalman A. MacLennan, Francesco BertiPaolo Costantino. (2013) Development of a glycoconjugate vaccine to prevent meningitis in Africa caused by meningococcal serogroup X. Proceedings of the National Academy of Sciences 110:47, pages 19077-19082.
Crossref
Crossref
Qingrui Huang, Dongxia Li, Aijun Kang, Wenqi An, Bei Fan, Xiaowei Ma, Guanghui Ma, Zhiguo Su & Tao Hu. (2013) PEG as a spacer arm markedly increases the immunogenicity of meningococcal group Y polysaccharide conjugate vaccine. Journal of Controlled Release 172:1, pages 382-389.
Crossref
Crossref
Helen Findlow & Ray Borrow. (2013) Immunogenicity and Safety of a Meningococcal Serogroup A, C, Y and W Glycoconjugate Vaccine, ACWY-TT. Advances in Therapy 30:5, pages 431-458.
Crossref
Crossref
Jamie D. Croxtall & Sohita Dhillon. (2012) Meningococcal Quadrivalent (Serogroups A, C, W135 and Y) Tetanus Toxoid Conjugate Vaccine (Nimenrix™). Drugs 72:18, pages 2407-2430.
Crossref
Crossref